Morrison Briggs 4
4 · Syndax Pharmaceuticals Inc · Filed Jul 11, 2023
Insider Transaction Report
Form 4
Morrison Briggs
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Stock Options (Right to buy)
2023-07-10−52,855→ 0 totalExercise: $8.77Exp: 2027-02-06→ Common Stock (52,855 underlying) - Sale
Common Stock
2023-07-10$20.40/sh−52,855$1,078,068→ 17,836 total - Exercise/Conversion
Common Stock
2023-07-10$8.77/sh+52,855$463,538→ 70,691 total
Footnotes (3)
- [F1]Following the sales reported in this Form 4, the Reporting Person has a total of 601,143 options to purchase shares of common stock that are vested and immediately exercisable and a total of 258,729 options to purchase shares of common stock that have not yet vested.
- [F2]The sale prices ranged from $20.11 to $20.71.
- [F3]This option is fully vested.